Bridgewater Biotech Campus Gets More Tenants

BRIDGEWATER, NJ—Advance Realty and CrossHarbor Capital Partners have leased 11,000 square feet at the New Jersey Center of Excellence in Bridgewater, NJ to several new tenants.

Since acquiring the Bridgewater, NJ, campus from Sanofi-Aventis in 2014, the partnership has successfully repositioned the site into New Jersey's premier research and development campus. As reported by GlobeSt.com, last month Nestlé Health Science leased 180,000 square feet of research and development space at the site.

"We are pleased to be able to accommodate tenants of various sizes at the Center of Excellence,ranging from 2,500 to 150,000 square feet," Kurt Padavano, chief operating officer of Advance Realty tells GlobeSt.com exclusively. "Our current tenant roster reflects a variety of research and development companies, including Ashland, Nestlé and Amneal, among others. As anticipated, companies in the biotech space find our campus extremely attractive, largely due to the superior infrastructure in place and the access it offers to the local, qualified workforce. We look forward to offering our tenants and prospective tenants additional onsite campus amenities -- including the planned hotel -- and are currently moving through the approvals process with the planning board and town council."

New tenants signed this month are:

• Clinical Genomics, a US-based biotechnology company that manufactures, markets and distributes a leading-edge product for colorectal cancer screening. Clinical Genomics was represented by Mary Ryan, president of Franzwa Real Estate Advisors.

• GSG Scientific, which provides support for research projects in the food and healthcare industries.

• Solaris Pharma, a company engaged in the development of generic and branded pharmaceutical products in the topical and transdermal sector. 
• Matinas BioPharma Holdings, a clinical-stage biopharmaceutical company developing products to treat infectious diseases.

Advance Realty and CrossHarbor Capital Partners were represented by the Jones Lang LaSalle team of Daniel Loughlin, international director, Robert Ryan and Craig Eisenhardt, senior vice presidents, and Scott Stange, vice president.

"These transactions demonstrate continued momentum in this region and the strong desire from next-generation innovators of all sizes to be located in the Center of Excellence," says Peter J. Cocoziello, founder and CEO of Advance Realty. "We're thrilled that our campus is attracting the cutting-edge companies that are integral to both the region's long-term success and to improving peoples' lives with their discoveries."

An emerging regional hub for innovation and discovery, NJCOE has an existing infrastructure suited for biotechnology and pharmaceutical companies that includes state-of-the-art lab facilities, redundant utilities and cutting-edge communications capabilities. The campus is also attractive to firms in the electronics, food and nutrition, cosmetics, and research and development space.

Situated on 110 acres directly off Route 202/206, with more than a quarter-mile of frontage on Interstate 287, the property is centrally located within the heart of New Jersey's life science corridor. It offers convenient access to Interstates 78 and 287 as well as the Garden State Parkway, New Jersey Turnpike/I-95 and Routes 22 and 28.